Keybank National Association OH Acquires 697,613 Shares of Axon Enterprise, Inc $AXON

Posted by George Bondi on Nov 11th, 2026

Keybank National Association OH raised its holdings in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 68,460.5% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 698,632 shares of the biotechnology company’s stock after acquiring an additional 697,613 shares during the quarter. Axon Enterprise comprises approximately 1.0% of Keybank National Association OH’s investment portfolio, making the stock its 22nd largest holding. Keybank National Association OH’s holdings in Axon Enterprise were worth $295,186,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. State Street Corp increased its position in shares of Axon Enterprise by 5,700.2% during the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after acquiring an additional 209,879,882 shares during the period. Envestnet Asset Management Inc. raised its stake in shares of Axon Enterprise by 18,050.2% in the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after acquiring an additional 13,127,348 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its stake in shares of Axon Enterprise by 391,214.9% in the third quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock valued at $2,952,943,000 after acquiring an additional 6,987,098 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in Axon Enterprise by 5,022.8% in the third quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock valued at $1,802,719,000 after purchasing an additional 4,183,302 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its holdings in Axon Enterprise by 8,432.6% in the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock valued at $1,983,414,000 after purchasing an additional 3,496,493 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Positive Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will become its U.S. public-safety distributor. The deal could broaden Axon’s public-safety technology offering, though its scale also brings investment and execution risks. Axon invests in Skydio
Positive Sentiment: West Fargo police plan to replace Flock technology with Axon’s system, including new AI features—an example of continued adoption by public-safety customers. West Fargo police adoption
Positive Sentiment: Despite lowering its price target, Barclays retained an “overweight” rating at $507; Northland reportedly still sees a $540 target after the stock’s steep fall from its August high. These views suggest some analysts see substantial recovery potential, though targets are not guarantees. Northland target outlook
Neutral Sentiment: A short-interest report lists 0 shares short, despite describing a large increase. The figure appears inconsistent and does not provide a reliable indication of short-selling pressure.
Negative Sentiment: Axon’s third-quarter adjusted EPS of $1.72 and revenue of about $909 million fell short of estimates. Cautious guidance and roughly $130 million in federal-contract revenue shifting out of 2026 have weighed on the outlook; shares have fallen sharply since the results, while Motorola rose after its earnings beat. Axon versus Motorola after earnings
Negative Sentiment: Law firms announced investigations into potential securities-law violations. These are allegations under investigation, not findings of wrongdoing, but may add legal and reputational uncertainty for investors. Axon securities investigation notice

Analysts Set New Price Targets

Several research analysts recently commented on AXON shares. The Goldman Sachs Group lowered their target price on Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a research note on Monday, September 21st. Morgan Stanley upped their price target on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Northland Securities set a $540.00 price target on Axon Enterprise in a research report on Friday. Northcoast Research lifted their price objective on Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a research note on Tuesday, August 11th. Finally, Needham & Company LLC decreased their price objective on Axon Enterprise from $750.00 to $500.00 and set a “buy” rating for the company in a research note on Friday, November 6th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $612.18.

Get Our Latest Report on Axon Enterprise

Insider Activity

In related news, insider Isaiah Fields sold 1,017 shares of the stock in a transaction on Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the transaction, the insider owned 56,264 shares of the company’s stock, valued at $27,032,038.80. This represents a 1.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the transaction, the chief executive officer directly owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 37,397 shares of company stock worth $21,234,034. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Trading Down 0.2%

NASDAQ AXON opened at $302.54 on Wednesday. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76. Axon Enterprise, Inc has a 52 week low of $291.45 and a 52 week high of $665.07. The stock has a market capitalization of $24.58 billion, a PE ratio of 96.97, a price-to-earnings-growth ratio of 5.76 and a beta of 1.48. The firm has a 50 day moving average of $430.30 and a two-hundred day moving average of $472.14.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The firm had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. During the same quarter in the previous year, the business posted $1.17 earnings per share. Axon Enterprise’s revenue for the quarter was up 27.8% compared to the same quarter last year. As a group, research analysts expect that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.